Related Experiment Video
Updated: Aug 5, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
How opioids inhibit GABA-mediated neurotransmission
C W Vaughan1, S L Ingram, M A Connor
1Department of Pharmacology, The University of Sydney, New South Wales, Australia. chrisv@pharmacol.usyd.edu.au
Nature
|December 24, 1997
Summary
Opioid pain relief in the midbrain involves suppressing GABA inhibition via a potassium channel. This pathway, involving specific enzymes, explains how opioids and NSAIDs work together for analgesia.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- The periaqueductal grey (PAG) in the midbrain is crucial for pain modulation, rich in opioid receptors.
- Opioid analgesia is thought to involve inhibiting GABAergic neurotransmission in the PAG's descending antinociceptive pathways.
- The precise presynaptic mechanisms of opioid inhibition of GABAergic transmission remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying opioid inhibition of GABAergic synaptic transmission in the PAG.
- To identify the specific signaling pathway linking mu-opioid receptors to presynaptic inhibition.
Main Methods:
- Electrophysiological recordings of GABAergic synaptic currents in the PAG.
- Pharmacological manipulation using opioid receptor agonists and enzyme inhibitors (phospholipase A2, cyclooxygenase, lipoxygenases).
Main Results:
- Opioid inhibition of GABAergic transmission in the PAG is mediated by a presynaptic voltage-dependent potassium conductance.
- Mu-opioid receptors are coupled to this potassium conductance via a pathway involving phospholipase A2, arachidonic acid, and 12-lipoxygenase.
- Inhibitors of cyclooxygenase and 5-lipoxygenase potentiate opioid inhibition, suggesting increased substrate availability for 12-lipoxygenase.
Conclusions:
- A specific signaling cascade involving potassium channels and arachidonic acid metabolites mediates opioid-induced suppression of GABAergic transmission in the PAG.
- These findings explain the analgesic effects of cyclooxygenase inhibitors and their synergy with opioids in pain management.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
10:53Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
Related Concept Videos
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...